Skip to main content
Screener/Healthcare/Biotechnology

VKTX — Viking Therapeutics, Inc.

NASDAQ
$34.29+1.91 (+5.90%)
Mid CapUnder $50HealthcareGLP-1 / Weight LossLow Beta
$22.96
$43.15
$31.76
$35.90
EPS (TTM)$-4.14
P/E Ratio-10.27
Dividend Yield—
Market Cap$3.53B
Volume5.32M
Prev Close$32.37
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$158.3M$-1.37——
Q4 '25$0-$157.7M$-1.38——
Q3 '25$0-$90.8M$-0.81——
Q2 '25$0-$65.6M$-0.58——
Q1 '25$0-$45.6M$-0.41——
Q4 '24$0-$35.4M$-0.32——
Q3 '24$0-$24.9M$-0.22——
Q2 '24$0-$22.3M$-0.20——
Get Your Daily Market Recap